84973-05-7

Basic information

• Product Name: 3-Bromo-7-chloroquinoline
• Synonyms: 3-Bromo-7-chloroquinoline
• CAS NO: 84973-05-7
• Molecular Formula: C9H5BrClN
• Molecular Weight: 242
• Mol File: 84973-05-7.mol

Chemical Properties

• Boiling Point: 311.8±22.0 °C(Predicted)
• Appearance: /
• Density: 1.673±0.06 g/cm3(Predicted)
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 0.95±0.25(Predicted)
• CAS DataBase Reference: 3-Bromo-7-chloroquinoline(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Bromo-7-chloroquinoline(84973-05-7)
• EPA Substance Registry System: 3-Bromo-7-chloroquinoline(84973-05-7)

Safety Data

• Hazardous Substances Data: 84973-05-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical and Agrochemical Industries:
3-Bromo-7-chloroquinoline is utilized as a key building block for the synthesis of various pharmaceuticals and agrochemicals, leveraging its versatile reactivity and functional group compatibility to create effective and novel compounds for medical and agricultural applications.
Used in Materials Science:
In the field of materials science, 3-Bromo-7-chloroquinoline is employed as a component in the development of new materials, contributing to the advancement of research and industrial applications through its unique chemical properties.
Used in Organic Dyes and Optical Brighteners Production:
3-Bromo-7-chloroquinoline has demonstrated its potential as a key intermediate in the production of organic dyes and optical brighteners, playing a significant role in enhancing the color and brightness of various products.
Overall, 3-Bromo-7-chloroquinoline's multifaceted applications across different industries underscore its importance in the development of innovative solutions in medicine, agriculture, and materials science.

Upstream product

• 1195710-15-6 3-amino-7-chloroquinoline 
• 22931-74-4 4,7-dichloro-3-nitroquinoline 
• 5350-50-5 7-chloro-3-nitro-4-hydroxyquinoline 
• 86-99-7 7-chloro-4-hydroxylquinoline 

Relevant articles and documents

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with a defect in glyoxylate metabolism, for example a disease or disorder associated with the enzyme glycolate oxidase (GO) or alterations in oxalate metabolism. Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme glycolate oxidase (GO). Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.